|
Education
| | | | |
|
Low
|
4
|
3.9
|
18
|
17.6
|
|
Medium
|
48
|
47.1
|
42
|
41.2
|
|
High
|
47
|
46.1
|
36
|
35.3
|
|
Unknown
|
3
|
2.9
|
6
|
5.9
|
|
Marital status
| | | | |
|
Couple
|
79
|
77.5
|
76
|
74.5
|
|
Single
|
20
|
19.6
|
20
|
19.6
|
|
Unknown
|
3
|
2.9
|
6
|
5.9
|
|
Menopausal status
| | | | |
|
Premenopausal
|
48
|
47.1
|
67
|
65.7
|
|
Postmenopausal
|
45
|
44.1
|
33
|
32.4
|
|
Unknown
|
9
|
8.8
|
2
|
2.0
|
|
Radiotherapy
| | | | |
|
No
|
30
|
29.4
|
33
|
32.4
|
|
Yes
|
72
|
70.6
|
69
|
67.6
|
|
Tissue expander
| | | | |
|
No
|
93
|
91.2
|
92
|
90.2
|
|
Yes
|
9
|
8.8
|
10
|
9.8
|
|
Her2, ER, and PR receptors
| | | | |
|
Triple negative
|
24
|
23.5
|
12
|
11.8
|
|
Her2Neu+, ER+, or PR+
|
11
|
10.8
|
18
|
17.6
|
|
Her2Neu+, ER–, and PR–
|
10
|
9.8
|
2
|
2.0
|
|
Her2Neu–, ER+, or PR+
|
57
|
55.9
|
70
|
68.6
|
|
Adjuvant treatment started before recruitment
| | | | |
|
Chemotherapy
|
36
|
35.3
|
36
|
35.3
|
|
Radiotherapy
|
27
|
26.5
|
35
|
34.3
|
|
None
|
39
|
38.2
|
31
|
30.4
|
| |
Mean
|
SD
|
Mean
|
SD
|
|
Age (years)
|
49.7
|
8.2
|
49.5
|
7.9
|
|
Height (cm)
|
168.1
|
6.6
|
169.1
|
6.5
|
|
Weight (kg)
|
72.8
|
13.2
|
76.0
|
15.4
|
|
BMI (kg/m2)
|
25.8
|
4.4
|
26.6
|
5.2
|
| |
Median
|
IQR
|
Median
|
IQR
|
|
Moderate to high intensity total PA performed before diagnosis (min/week)*
|
485
|
240–975
|
600
|
300–1440
|
|
Moderate to high intensity leisure and sport PA performed before diagnosis (min/week)
|
180
|
50–375
|
173
|
60–330
|
